文献速递临床免疫分子诊断

重新开发用于大鼠戊型肝炎病毒诊断的抗原检测试剂盒

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus.
PubMed 文献 · J Clin Microbiol · 2023-12-01

本研究采用酶免疫分析法(EIA),利用一组戊型肝炎病毒(HEV)特异性单克隆抗体检测大鼠HEV(r HEV)和巴厘岛HEV(b HEV)的重组病毒样颗粒蛋白(HEV 239)。筛选出捕获抗体P#1-H4与检测抗体C145(P#1-H4*/C145#)及C158(P#1-H4*/C158#)两个候选组合。在b HEV感染的临床样本中,两候选组合诊断效能与万泰HEV抗原试剂盒相似;万泰试剂盒对r-1 HEV感染检测效能低(0%,0/10),P#1-H4*/C145#为80%(8/10),P#1-H4*/C158#为100%(10/10)。两候选组合结合于r HEV和b HEV高度保守的离散抗原位点。

要点

  • 万泰HEV抗原试剂盒对r-1 HEV感染检测效能为0%(0/10)。
  • P#1-H4*/C158#对r-1 HEV感染临床样本诊断效能达100%(10/10)。
  • P#1-H4*/C145#对r-1 HEV感染临床样本诊断效能为80%(8/10)。

核心结论

  • P#1-H4*/C145#和P#1-H4*/C158#是有效的大鼠HEV抗原检测候选抗体组合。

研究设计与样本

  • 采用酶免疫分析法(EIA),使用HEV特异性单克隆抗体检测r HEV和b HEV的重组病毒样颗粒蛋白(HEV 239)。
  • 在感染大鼠样本及r-1 HEV或b HEV感染的人临床样本中评估候选抗体组合。

主要发现

  • 两候选组合在b HEV感染临床样本中诊断效能与万泰HEV抗原试剂盒相似。
  • 万泰HEV抗原试剂盒检测r-1 HEV感染的效能为0%(0/10)。
  • P#1-H4*/C145#检测r-1 HEV感染的效能为80%(8/10)。
  • P#1-H4*/C158#检测r-1 HEV感染的效能为100%(10/10)。
  • 两候选组合结合于r HEV和b HEV高度保守的离散抗原位点。

关键数值与推荐

  • 万泰HEV抗原试剂盒对r-1 HEV感染检出0%(0/10)。
  • P#1-H4*/C145#对r-1 HEV感染检出80%(8/10)。
  • P#1-H4*/C158#对r-1 HEV感染检出100%(10/10)。

临床怎么用

  • P#1-H4*/C158#和P#1-H4*/C145#可作为大鼠HEV抗原检测的候选抗体组合用于后续开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The emergence of Rocahepevirus ratti [species HEV ratti (r HEV)] as a causative agent of hepatitis E in humans presents a new potential threat to global public health. The R. ratti genotype 1 (r-1 HEV) variant only shares 50%-60% genomic identity with Paslahepevirus balayani [species HEV balayani (b HEV)] variants, which are the main causes of hepatitis E infection in humans. Here, we report antigen diagnoses for r-1 HEV and b HEV using an enzymatic immunoassay (EIA) method. We detected recombinant virus-like particles protein (HEV 239) of r HEV and b HEV using a collection of hepatitis E virus (HEV)-specific monoclonal antibodies. Two optimal candidates, the capture antibody P#1-H4 and the detection antibodies C145 (P#1-H4*/C145#) and C158 (P#1-H4*/C158#), were selected to detect antigen in infected rat samples and r-1 HEV- or b HEV-infected human clinical samples. The two candidates showed similar diagnostic efficacy to the Wantai HEV antigen kit in b HEV-infected clinical samples. Genomic divergence resulted in low diagnostic efficacy of the Wantai HEV antigen kit (0%, 0 of 10) for detecting r-1 HEV infection. Compared with the P#1-H4*/C145# candidate (80%, 8 of 10), the P#1-H4*/C158# candidate had excellent diagnostic efficacy in r-1 HEV-infected clinical samples (100%, 10 of 10). The two candidates bind to a discrete antigenic site that is highly conserved across r HEV and b HEV. P#1-H4*/C145# and P#1-H4*/C158# are efficacious candidate antibody combinations for rat HEV antigen detection.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Chen Z, Li G, Situ J, et al. Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus. J Clin Microbiol. 2023. PMID: 38038482. doi:10.1128/jcm.00710-23

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。